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recently been stressed (Fitzgerald, ClGn. exp.
Immunol., 1971, 8, 421). Twenty-one
patients and the same number of age-
matched controls were studied. Lympho-
cyte transformation was induced at seven
concentrations of PHA and the response
measured by the incorporation of [14C]-
thymidine. Using the data obtained, dose
response curves were plotted for both the
cancer and control patients. A statistically
highly significant difference between the two
groups emerged at three different concentra-
tions. This was considered to reflect a
depression in " T " lymphocyte function but
it was not possible to say whether this was
due to a deficiency in the cells themselves or
due to a serum inhibitory factor.
INHIBITION OF CELL MEDIATED
CYTOTOXICITY AGAINST HUMAN
COLON CARCINOMATA BY PAPAIN-
SOLUBILIZED TUMOUR MEMBRANE
EXTRACTS. M. J. EMBLETON and M. R.
PRICE. Cancer Research Campaign Labora-
tories, University of Nottingham.
Studies were undertaken to determine
whether soluble tumour antigen preparations
can infiuence cytotoxicity against cultured
colon carcinoma cells by lymphocytes from
colon carcinoma patients.
Peripheral lymphocytes from 61% of
tumour bearing or post-operative patients
were cytotoxic for colon carcinoma cells
compared with normal control lymphocytes,
as assayed by their capacity to reduce the
survival of target cells in microtitration
plates. Papain-solubilized membrane ex-
tracts were prepared from pooled colon
carcinomata, normal colon and melanoma,
and their effect on cell mediated cytotoxicity
was measured by incubation with patients'
and control lymphocytes before addition of
the lymphocytes to target cells. Colon
carcinoma extracts inhibited cytotoxicity
but normal colon or melanoma extracts had
no effect. The inhibition of lymphocyte
reactivity by soluble antigen may have
important implications regarding the possible
modification of tumour-immune reactions
in vivo by circulating tumour antigen.
BCG IMMUNOTHERAPY OF RAT
SARCOMATA. R. W. BALDWIN and M. V.
PIMM. Cancer Research Campaign Labora-
tories, University of Nottingham.
Growth of immunogenic 3-methylchol-
anthrene induced rat sarcomata was suppres-
sed if tumour cells were transplanted sub-
cutaneously in admixture with as little as
10 ,ug of viable BCG. Animals rejecting
sarcoma cell-BCG inocula were subsequently
immune to challenge with the same tumour,
indicating the involvement of host responses
to tumour associated rejection antigens.
Furthermore, rejection of mixed inocula
suppressed growth of a simultaneous chal-
lenge of the same sarcoma at another site.
This specific active immunotherapy was
successful even if given after tumour
challenge.
Pulmonary growth ofintravenously trans-
ferred sarcoma cells was also controlled by
this form of active immunotherapy. More
effective control was obtained by intra-
venous administration of BCG alone, even if
delayed up to 7 days after challenge, perhaps
reflecting preferential pulmonary survival of
BCG and direct contact with tumour cells at
this site.
THE ROLE OF MACROPHAGES IN
CLASSIC MAREK'S DISEASE. J. C.
CAMPBELL. Cancer Research Campaign
Unit, Department of Veterinary Pathology,
Bush House, Milton Bridge, Midlothian.
Marek's disease is a contagious lympho-
proliferative condition of chickens caused by
a herpesvirus Type B and exhibits neural
and visceral forms. Cells involved are
mainly lymphocytes and plasmacytes.
Lesions may terminate as lymphomata.
Indirect and direct immunofluorescence
of cryostat sections and serosal spreads show
antigen mainly confined to histiocytes,
though vascular endothelium and neurilemma
are frequently positive and lymphoid foci
occasionally so. Fresh buffy coat prepara-
tions show positively staining monocytes
which metamorphose in culture to motile
macrophages. Lymphocytes adhere to
these, forming conspicuous immunofluores-
cent clusters. Intercellular bridging be-
tween macrophages leads to the formation of
immunofluorescent-positive polykaryocytes.
Lymphocytes containing macrophage-en-
dowed viral genome respond to the blasto-
genic effect of phytohaemagglutinin in vitro
and naked nucleoplasmic virions appear
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